Phospholipid profiles and hepatocellular carcinoma risk and prognosis in cirrhotic patients.
Fiche publication
Date publication
mars 2019
Journal
Oncotarget
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BINQUET Christine, Pr DELMAS Dominique, Pr HILLON Patrick, Dr PAIS DE BARROS Jean-Paul, Dr COTTET Vanessa, Dr AIRES Virginie
Tous les auteurs :
Cotte AK, Cottet V, Aires V, Mouillot T, Rizk M, Vinault S, Binquet C, de Barros JP, Hillon P, Delmas D
Lien Pubmed
Résumé
Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide. Phospholipids are now well-recognised players in tumour progression. Their metabolic tissue alterations can be associated with plasmatic modifications. The aim of this study was to evaluate the potential of the plasma phospholipid profile as a risk and prognostic biomarker in HCC.
Mots clés
biomarker, case–control study, cirrhosis, hepatocellular carcinoma, phospholipids
Référence
Oncotarget. 2019 Mar 15;10(22):2161-2172